Novavax (NVAX) FCF Margin (2010 - 2026)
Novavax (NVAX) reported FCF Margin of -129.45% for Q2 2026, down 75.95 percentage points from -53.50% a year earlier and down 105.30 percentage points from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) FCF Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novavax's FCF Margin came in at -10.20%, up 48.80 percentage points year-over-year; for FY2025, it came in at -22.27%, down 7.56 percentage points from FY2024.
- FCF Margin has a five-year change of -1.87 percentage points (FY2020 to FY2025).
- By year, FCF Margin came in at -14.71% in FY2024 (+63.34 pp), -78.05% in FY2023 (-52.56 pp), -25.48% in FY2022 (-48.90 pp) and 23.42% in FY2021 (+43.82 pp).
- The Q2 2026 figure ranks as the lowest quarterly FCF Margin since Q4 2024.
- Year over year, FCF Margin gained in four of the last eight quarters, with an average year-over-year change of +10.66 percentage points.
- The high point for year-over-year FCF Margin in five years was Q1 2024 (a gain of 330.32 percentage points); the low point was Q1 2023 (a drop of 411.71 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -24.15% (Q1 2026), -28.21% (Q4 2025) and 151.04% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 28.96% |
| 10 | Novavax | 1.80 Bn | -1.06 Bn | 44.81 Mn | -139.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -139.52% |
| Jun 30, 2026 | -129.45% |
| Mar 31, 2026 | -24.15% |
| Dec 31, 2025 | -28.21% |
| Sep 30, 2025 | 151.04% |
| Jun 30, 2025 | -53.50% |
| Mar 31, 2025 | -28.07% |
| Dec 31, 2024 | -198.27% |
| Sep 30, 2024 | -172.98% |
| Jun 30, 2024 | 74.95% |
| Mar 31, 2024 | -96.35% |
| Dec 31, 2023 | -63.71% |
| Sep 30, 2023 | -30.92% |
| Jun 30, 2023 | -42.15% |
| Mar 31, 2023 | -426.67% |
| Dec 31, 2022 | -39.41% |
| Sep 30, 2022 | -8.62% |
| Jun 30, 2022 | -105.14% |
| Mar 31, 2022 | -14.96% |
| Dec 31, 2021 | -160.12% |
API Access
Novavax FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();